Wang, H., Fan, X., Zeng, T., Xie, L., Jiang, T., Wang, Q., Zhao, T., Zheng, S., Zhou, H., Xu, X., Hu, H., Wang, H., Yuan, Z., Dong, L. (2026). Bortezomib plus gemcitabine-cisplatin versus gemcitabine-cisplatin as first-line treatment for advanced biliary tract cancers: A randomized phase II clinical trial with exploratory analysis of PTEN status.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4112